.The purpose of the Administrative Core is to support the translational research objectives of the SPORE by providing: (1) management and coordination of the daily activities of the SPORE program, (2) administrative direction and structure for the investigators, (3) support for scientific activities of the SPORE investigators, and (4) scientific programmatic oversight of projects and cores in collaboration with internal and external advisory committees. The Administrative Core is responsible for the following: submission of reports and non-competing renewal applications to the NIH, facilitating communication among SPORE investigators, organization of conferences and seminars, management of the clinical soft tissue sarcoma database, coordination of the sarcoma soft tissue resource, and sponsored travel of SPORE investigators to scientific meetings. In addition, the core will schedule and coordinate the SPORE investigators'attendance at annual SPORE meetings and annual reviews by the Internal and External Scientific Advisory Committees. This core will assist David Spriggs, MD, in administering the Career Development Program, including promotion of the fellowship program and recruitment of minority participants. Finally, the Administrative Core, in conjunction with MSKCC's Office of Sponsored Projects, will administer the funds of the SPORE. This work will be performed under the direction of the Principal Investigator, Samuel Singer, MD.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA140146-04
Application #
8515350
Study Section
Special Emphasis Panel (ZCA1-GRB-I)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
4
Fiscal Year
2013
Total Cost
$64,435
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Tap, William D; Jones, Robin L; Van Tine, Brian A et al. (2016) Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial. Lancet 388:488-97
Argani, Pedram; Reuter, Victor E; Zhang, Lei et al. (2016) TFEB-amplified Renal Cell Carcinomas: An Aggressive Molecular Subset Demonstrating Variable Melanocytic Marker Expression and Morphologic Heterogeneity. Am J Surg Pathol 40:1484-1495
Specht, Katja; Zhang, Lei; Sung, Yun-Shao et al. (2016) Novel BCOR-MAML3 and ZC3H7B-BCOR Gene Fusions in Undifferentiated Small Blue Round Cell Sarcomas. Am J Surg Pathol 40:433-42
Kao, Yu-Chien; Sung, Yun-Shao; Zhang, Lei et al. (2016) BCOR Overexpression Is a Highly Sensitive Marker in Round Cell Sarcomas With BCOR Genetic Abnormalities. Am J Surg Pathol 40:1670-1678
McFadden, David G; Politi, Katerina; Bhutkar, Arjun et al. (2016) Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinoma. Proc Natl Acad Sci U S A 113:E6409-E6417
Patwardhan, Parag P; Ivy, Kathryn S; Musi, Elgilda et al. (2016) Significant blockade of multiple receptor tyrosine kinases by MGCD516 (Sitravatinib), a novel small molecule inhibitor, shows potent anti-tumor activity in preclinical models of sarcoma. Oncotarget 7:4093-109
Leduc, Charles; Zhang, Lei; Öz, Buge et al. (2016) Thoracic Myoepithelial Tumors: A Pathologic and Molecular Study of 8 Cases With Review of the Literature. Am J Surg Pathol 40:212-23
Kao, Yu-Chien; Sung, Yun-Shao; Zhang, Lei et al. (2016) Recurrent BCOR Internal Tandem Duplication and YWHAE-NUTM2B Fusions in Soft Tissue Undifferentiated Round Cell Sarcoma of Infancy: Overlapping Genetic Features With Clear Cell Sarcoma of Kidney. Am J Surg Pathol 40:1009-20
Moore, Amanda R; Ceraudo, Emilie; Sher, Jessica J et al. (2016) Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma. Nat Genet 48:675-80
Huang, Shih-Chiang; Alaggio, Rita; Sung, Yun-Shao et al. (2016) Frequent HRAS Mutations in Malignant Ectomesenchymoma: Overlapping Genetic Abnormalities With Embryonal Rhabdomyosarcoma. Am J Surg Pathol 40:876-85

Showing the most recent 10 out of 108 publications